Skip to main content
IART logo

Integra LifeSciences Holdings Corporation

IARTNASDAQHealthcareMedical Devices

$12.10Today:- (-)1Y −22.39%

As of Oct 26, 2026 close

Market cap
$950.78M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.70$20.49
Volume (live)
-
Avg. volume (3M)
1.17M

Integra LifeSciences Holdings (IART) Stock Price & Financial Analysis

Integra LifeSciences Holdings Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$12.00 - $12.24
52-Week High$20.49
52-Week Low$8.70
Open$12.05
Volume (last close)916.42K
Average Volume (3M)1.17M
Earnings & Profitability
Revenue (TTM)1.66B
Net Income (TTM)-7.24M
Free Cash Flow (TTM)71.58M
EPS (TTM)−$0.09
Profit Margin-0.44%
Operating Margin7.41%
Return on Equity (ROE)-0.69%
Debt to Equity1.80
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJul 2, 2015
Size & Valuation
Market Cap950.78M
Shares Outstanding78.58M
Price to Sales (P/S)0.57
Price to Book (P/B)0.89
EV/EBITDA10.05
Technical Indicators
50-Day MA$15.68
200-Day MA$14.10
1-Year Change−22.39%

Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology

Compare IART with other stocks

Integra LifeSciences Holdings at a Glance

As of the Oct 26, 2026 close, Integra LifeSciences Holdings (IART) has a market capitalization of $950.78M. The stock trades at 0.6× sales. Over the trailing twelve months it lost $7.24M on revenue of $1.66B and generated $71.58M of free cash flow. Revenue grew 0.8% year over year.

As of its latest reported balance sheet, it holds $252.26M in cash and securities against $1.88B of debt, a net debt position of $1.63B.

Integra LifeSciences Holdings does not currently pay a dividend.

The share price is down 22.4% over the past year. At $12.10 (the Oct 26, 2026 close) it sits within its 52-week range of $8.70 to $20.49, below its 200-day moving average of $14.10.

Based on 12 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $14.88, 23.0% above the Oct 26, 2026 close.

Frequently Asked Questions About Integra LifeSciences Holdings

What is the current stock price for IART?

As of the Oct 26, 2026 close, IART stock trades at $12.10. The 52-week range is $8.70–$20.49, with a day range of $12.00–$12.24.

What is the P/E ratio for IART?

The P/E ratio (Price-to-Earnings) for IART is shown in the Key Statistics section. This valuation metric helps compare Integra LifeSciences Holdings Corporation to industry peers.

Does IART pay dividends?

Integra LifeSciences Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for IART?

Based on ratings from 12 professional analysts over the last 90 days, the consensus for IART is Hold. The average 12-month price target is $14.88, a 23.0% upside from the Oct 26, 2026 close of $12.10.

What is the market cap of IART?

As of the Oct 26, 2026 close, Integra LifeSciences Holdings's market capitalization is $950.8M, classifying it as a small-cap company. Integra LifeSciences Holdings operates in the Healthcare sector within the Medical Devices industry.